STK33 and familial pancreatic carcinoma: In an attempt to address this issue we found that STK33 overexpression in MIA PaCa2 pancreatic cancer cells was associated with augmented kinase activity and expression of PKD2 (Figure 8), another serine/threonine kinase described as a client of HSP90 [14].